查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529792

胜肽微陣列市場規模、佔有率、趨勢分析報告：按類型、應用、最終用途、地區和細分市場預測，2024-2030 年

Peptide Microarray Market Size, Share & Trends Analysis Report By Type (Reagents, Services), Application (Disease Diagnostics, Protein Functional Analysis), By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

勝胜肽微陣列市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計2030年全球勝胜肽微陣列市場規模將達到4.273億美元，2024年至2030年複合年成長率為6.18%。

預計市場在預測期內將保持穩定成長。該技術包括臨床分析和蛋白質體學領域的高通量技術。胜肽微陣列可以透過光譜、質譜和螢光成像進行分析。它在醫學、藥學、生物學等領域有著廣泛的應用。它是一種先進的自動化技術，可以從實驗中收集大量資料，用於尋找治療方法、診斷疾病和開發診斷技術。

此方法用於識別新的藥物標靶。細菌蛋白表面抗原的檢測、抗體測定、免疫抗原性鑑定、表位作圖、生物標記檢驗、血清分析、酵素表徵、HLA 分析等是胜肽微陣列的一些應用。使用胜肽微陣列進行診斷測試開發被認為是行業成長的關鍵決定因素。根據 2021 年 3 月發表的一項研究，胜肽微陣列可以為開發基於 COVID-19 的診斷測試提供抗原的重要見解。調查團隊使用胜肽微陣列來篩檢樣本中的病毒抗體。因此，基於胜肽微陣列的測試方法的發展有望促進該行業的成長。

例如，JPT Peptide Technologies 將用於 COVID-19 和感染疾病的勝胜肽微陣列商業化，零售價為 324 美元。該技術可用於免疫檢測和監測、生物標記發現以及蛋白質相互作用檢驗。主要企業正致力於策略性努力，在全球範圍內建立強大的分銷網路。例如，PEPperPRINT GmbH、4A Biotech Co. Ltd.、Filgen, Inc.、Tokyo Mirai Style、AbClon Inc.、Tokyo Mirai Style Taiwan、Sciencewerke Co.。這項策略使公司能夠避免監管和客戶獲取成本。

胜肽微陣列市場報告亮點

  • 由於許多製藥和生物技術公司建立了內部研究站進行抗體研究，設備類型細分市場相對比服務細分市場更加成熟，並且在 2023 年佔據最大佔有率。
  • 由於新興市場感染疾病的高流行，疾病診斷應用領域在 2023 年佔據了最大的銷售佔有率。例如，PEPperPRINT GmbH 提供針對超過 32 種感染疾病的胜肽微陣列。
  • 製藥和生物技術公司的最終用戶部分在 2023 年佔據了最大的收益佔有率，因為它廣泛用於抗體表徵和蛋白質相互作用檢驗。
  • 由於該地區醫療保健設施的建立以及研發領域投資的增加，北美地區在 2023 年的總收益中所佔佔有率最大。
  • 醫療保健專業人員和患者對慢性病早期發現和治療的認知不斷提高，也提高了診斷能力並推動了該地區的成長。
  • 此外，慢性病和感染疾病等疾病的日益普及正在促使企業進入該區域市場。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章胜肽微陣列市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 胜肽微陣列市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第 4 章胜肽微陣列市場：按類型估計和趨勢分析

  • 細分儀表板
  • 全球勝胜肽微陣列市場：按類型分類的變異分析
  • 全球勝胜肽微陣列市場：2018-2030 年按類型分類的規模和趨勢分析
  • 裝置
  • 試劑
  • 服務

第5章胜肽微陣列市場：按應用估算和趨勢分析

  • 細分儀表板
  • 全球勝胜肽微陣列市場：依應用進行變異分析
  • 全球勝胜肽微陣列市場：規模和趨勢分析（按應用），2018-2030
  • 疾病診斷
  • 蛋白質功能分析
  • 抗體表徵
  • 藥物發現

第6章胜肽微陣列市場：按最終用途分類的估計和趨勢分析

  • 細分儀表板
  • 全球勝胜肽微陣列市場：最終用途的變異分析
  • 全球勝胜肽微陣列市場：規模和趨勢分析（按最終用途），2018-2030 年
  • 製藥和生物技術公司
  • 醫院/診所
  • 診斷中心
  • 其他

第7章胜肽微陣列市場：區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域應用市場儀表板
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
    • 2018年至2030年北美市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018年至2030年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太市場估計與預測
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018年至2030年拉丁美洲市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018年至2030年中東和非洲市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/上市公司
    • PEPperPRINT GmbH
    • RayBiotech, Inc.
    • Creative Biolabs.
    • Aurora Biomed Inc.
    • Kinexus Bioinformatics Corporation
    • Bio-Synthesis Inc.
    • Microarrays Inc.
    • Arryait Corporation（ARYC）.
    • JPT Peptide Technologies
    • Merck KGaA
    • Innopsys
    • Nimble Therapeutics, Inc.
Product Code: GVR-4-68040-028-1

Peptide Microarray Market Growth & Trends:

The global peptide microarray market size is expected to reach USD 427.3 million by 2030, registering a CAGR of 6.18% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness a stable growth rate during the forecast period. The technique includes high throughput technologies in the area of clinical assays and proteomics. Peptide microarray can be analyzed through spectroscopy, mass spectrometry, and imaging via fluorescence. It has considerable applications in the field of medicine, pharmacology, and biology. It is one of the automated advanced technologies to collect a large volume of data from an experiment employed for therapeutic discoveries, disease diagnosis, and diagnostic technique development.

The method is employed to identify new drug targets. To detect the antigen present on the protein surface of bacteria, determination of Abs, immunogenic Identification, mapping of the epitope, biomarker validation, serum profiling, enzyme characterization, and HLA profiling are some of the applications of the peptide microarray. The use of peptide microarray for developing diagnostic tests is considered to be an important determinant of industry growth. According to research published in March 2021, peptide microarray can offer significant insights into the antigens for developing the COVID-19-based diagnostic test. Researchers used peptide microarrays to screen the samples for antibodies against the virus. Hence, the development of peptide microarray-based tests is expected to boost industry growth.

For instance, JPT Peptide Technologies commercializes peptide microarray for COVID-19 and infectious conditions at the retail price of USD 324. The technology can be used for immune detection and monitoring, biomarker discovery, and protein interaction validation. Key players are focusing on strategic initiatives to establish a strong distribution network across the globe. For instance, PEPperPRINT GmbH created its presence in the Asia Pacific regional market through distributors such as 4A Biotech Co., Ltd., Filgen, Inc., Tokyo Future Style, Inc., AbClon Inc., Tokyo Future Style Taiwan, Inc., Sciencewerke Co., Ltd., and TrendBio. The company adopted an indirect distribution strategy in the region. The strategy assisted the company to avoid the costs of regulatory compliance and customer acquisitions.

Peptide Microarray Market Report Highlights:

  • The instruments type segment is relatively more mature than the services segment and held the largest share in 2023 due to the high number of pharma & biotech companies establishing in-house research stations for antibody-based research
  • The disease diagnostics application segment captured the largest revenue share in 2023 owing to the high incidence of infectious diseases in emerging markets. For instance, PEPperPRINT GmbH offers peptide microarray for over 32 infectious conditions
  • The pharmaceutical & biotechnology companies end-user segment held the maximum revenue share in 2023 due to the wide use of antibody characterization and validation of protein interactions
  • North America accounted for the largest share of the overall revenue in 2023 due to the well-established healthcare facilities in this region along with increased investment in the R&D sector
  • The rising awareness among healthcare professionals and patients about the early detection and treatment of chronic diseases also speeds up diagnostic capabilities and boosts the region's growth
  • Moreover, the increasing incidence of diseases, such as chronic and infectious diseases, is encouraging companies to enter the regional market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Peptide Microarrays Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing burden of chronic diseases
      • 3.2.1.2. Technological advancements in diagnostic testing
      • 3.2.1.3. Rising adoption of peptide microarrays
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Reimbursement issues
  • 3.3. Peptide Microarrays Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Peptide Microarrays Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Peptide Microarrays Market Type Movement Analysis
  • 4.3. Global Peptide Microarrays Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Reagents
    • 4.5.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Peptide Microarrays Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Peptide Microarrays Market Application Movement Analysis
  • 5.3. Global Peptide Microarrays Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Disease Diagnosis
    • 5.4.1. Disease diagnosis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Protein Functional Analysis
    • 5.5.1. Protein functional analysis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Antibody Characterization
    • 5.6.1. Antibody characterization market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Drug Discovery
    • 5.7.1. Drug discovery market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Peptide Microarrays Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Peptide Microarrays Market End Use Movement Analysis
  • 6.3. Global Peptide Microarrays Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Hospitals & Clinics
    • 6.5.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Diagnostic Centers
    • 6.6.1. Diagnostic centers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Peptide Microarrays Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. PEPperPRINT GmbH
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. RayBiotech, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Creative Biolabs.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Aurora Biomed Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Kinexus Bioinformatics Corporation
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Bio-Synthesis Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Microarrays Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Arryait Corporation (ARYC).
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. JPT Peptide Technologies
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
    • 8.4.10. Merck KGaA
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Innopsys
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Nimble Therapeutics, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global peptide microarray market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 North America peptide microarray market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 10 U.S. peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 Canada peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 16 Mexico peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe peptide microarray market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 23 Germany peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 26 UK peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 27 UK peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 France peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 30 France peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 31 France peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 32 Italy peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 35 Spain peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 Denmark peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 41 Sweden peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 42 Sweden peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 44 Norway peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific peptide microarray market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 China peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 52 China peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 53 China peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 54 Japan peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 55 Japan peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 57 India peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 58 India peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 59 India peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 60 South Korea peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 63 Australia peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 64 Australia peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Thailand peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 69 Latin America peptide microarray market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 73 Brazil peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 74 Brazil peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 76 Argentina peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 MEA peptide microarray market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 81 MEA peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 82 MEA peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 83 South Africa peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 89 UAE peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait peptide microarray market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Peptide microarray market: Market outlook
  • Fig. 5 Peptide microarray market: Segment outlook
  • Fig. 6 Peptide microarray market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Peptide microarray market driver impact
  • Fig. 9 Peptide microarray market restraint impact
  • Fig. 10 Peptide microarray market: Type outlook and key takeaways
  • Fig. 11 Peptide microarray market: Type movement analysis
  • Fig. 12 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Reagents microarray market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Services microarray market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Peptide microarray market: Application outlook and key takeaways
  • Fig. 16 Peptide microarray market: Application movement analysis
  • Fig. 17 Disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Protein functional analysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Antibody characterization market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 20 Drug discovery market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 21 Peptide microarray market: End Use outlook and key takeaways
  • Fig. 22 Peptide microarray market: End Use movement analysis
  • Fig. 23 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 24 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Diagnostic centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Global peptide microarray market: Regional outlook and key takeaways
  • Fig. 28 Global peptide microarray market: Regional movement analysis
  • Fig. 29 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Key country dynamics
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Key country dynamics
  • Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)